Literature DB >> 15754415

Clostridium difficile causing acute renal failure: case presentation and review.

Jasmin Arrich1, Gottfried-H Sodeck, Gurkan Sengolge, Christoforos Konnaris, Marcus Mullner, Anton-N Laggner, Hans Domanovits.   

Abstract

AIM: Clostridium difficile infection is primarily a nosocomial infection but asymptomatic carriers of Clostridium difficile can be found in up to 5% of the general population. Ampicillin, cephalosporins and clindamycin are the antibiotics that are most frequently associated with Clostridium difficile-associated diarrhea or colitis. Little is known about acute renal failure as a consequence of Clostridium difficile-associated diarrhea.
METHODS: In this case report, we describe the course of Clostridium difficile-associated diarrhea in an 82-year-old patient developing acute renal failure. Stopping the offending agent and symptomatic therapy brought a rapid improvement of diarrhea and acute renal failure, full recovery was gained 18 d after admission. In a systematic review we looked for links between the two conditions.
RESULTS: The link between Clostridium difficile-associated diarrhea and acute renal failure in our patient was most likely volume depletion. However, in experimental studies a direct influence of Clostridium difficile toxins on renal duct cells could be shown.
CONCLUSION: Rapid diagnosis, nonspecific supportive treatment and specific antibiotic treatment, especially in the elderly, may lower excess mortality Clostridium difficile-associated diarrhea and renal failure being possible complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754415      PMCID: PMC4250724          DOI: 10.3748/wjg.v11.i8.1245

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Acute renal failure.

Authors:  Naveen Singri; Shubhada N Ahya; Murray L Levin
Journal:  JAMA       Date:  2003-02-12       Impact factor: 56.272

Review 2.  Prognosis of acute renal failure 1975-1995.

Authors:  W Druml
Journal:  Nephron       Date:  1996       Impact factor: 2.847

3.  Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.

Authors:  Mark A Miller; Meagan Hyland; Marianna Ofner-Agostini; Marie Gourdeau; Magued Ishak
Journal:  Infect Control Hosp Epidemiol       Date:  2002-03       Impact factor: 3.254

Review 4.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

Review 5.  The mechanisms of aquaporin control in the renal collecting duct.

Authors:  E Klussmann; K Maric; W Rosenthal
Journal:  Rev Physiol Biochem Pharmacol       Date:  2000       Impact factor: 5.545

6.  Association of IgA nephropathy with Clostridium difficile colitis.

Authors:  W J Gaughan; M H Hassan; P A McCue; J F Burke; K Sharma
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

7.  Clostridium difficile infection in patients with unexplained leukocytosis.

Authors:  Anna Wanahita; Elizabeth A Goldsmith; Bernard J Marino; Daniel M Musher
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

8.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department.

Authors:  Christopher N Andrews; Janet Raboud; Barry O Kassen; Robert Enns
Journal:  Can J Gastroenterol       Date:  2003-06       Impact factor: 3.522

Review 10.  The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.

Authors:  Brian W Hurley; Cuong C Nguyen
Journal:  Arch Intern Med       Date:  2002-10-28
View more
  7 in total

1.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

2.  Follow-up of Pseudomembranous Colitis in Children Using Colonoscopy: A Case Report.

Authors:  Q Zhao; H Yuan; H Hu; M Q Yan
Journal:  West Indian Med J       Date:  2015-04-17       Impact factor: 0.171

3.  Clostridium difficile Infection Hospitalizations in the United States: Insights From the 2017 National Inpatient Sample.

Authors:  Dhanshree Solanki; Asim Kichloo; Zain El-Amir; Dushyant Singh Dahiya; Jagmeet Singh; Farah Wani; Shantanu Solanki
Journal:  Gastroenterology Res       Date:  2021-04-21

4.  Acute Renal Failure in Association with Community-Acquired Clostridium difficile Infection and McKittrick-Wheelock Syndrome.

Authors:  Robert M Learney; Paul Ziprin; Pauline A Swift; Omar D Faiz
Journal:  Case Rep Gastroenterol       Date:  2011-08-18

5.  Immune profile of IgA-dominant diffuse proliferative glomerulonephritis.

Authors:  Eric Wallace; Nicolas Maillard; Hiroyuki Ueda; Stacy Hall; Huma Fatima; Jan Novak; Bruce A Julian
Journal:  Clin Kidney J       Date:  2014-10

6.  Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities.

Authors:  Chetana Vaishnavi; Pramod K Gupta; Megha Sharma; Rakesh Kochhar
Journal:  Gut Pathog       Date:  2019-04-23       Impact factor: 4.181

7.  Rate and predictors of 30-day readmission for clostridiodes difficile: a United States analysis.

Authors:  Asim Kichloo; Zain El-Amir; Dushyant Singh Dahiya; Mohammad Al-Haddad; Jagmeet Singh; Gurdeep Singh; Carlos Corpuz; Hafeez Shaka
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.